June 22, 2021

BSE Limited National Stock Exchange of India Limited Department of Corporate Services Exchange Plaza, Phiroze Jeejeebhoy Towers, Dalal Street Bandra Kurla Complex Mumbai — 400 001 Mumbai — 400 051

Scrip Code: 532771 Trading Symbol: JHS

Sub: Outcome of Meeting of Board of Directors held on Tuesday, 22" June,2021

Dear Sir/ Madam,

In accordance with Regulation 30 read with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations, 2015'), we wish to inform your good office that the Board of Directors of JHS Svendgaard Laboratories Limited ("the Company') at their meeting held today i.e. on Tuesday, June 22, 2021 has, inter alia, considered and approved the Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended on March 31, 2021.

The meeting of the Board of Directors commenced at_| 2° 'S4_ P.M. and concluded at_ 03° 1S P.M.

A Copy such Results along with Audit Reports thereon are enclosed as Annexure — A,

M/s S.N, Dhawan & Co. LLP, Chartered Accountants, the Statutory Auditors of the Company have issued auditors' reports with an unmodified opinion on the financial results.

These results are also being made available on the website of the Company at https://www.svendgaard.com.

You are requested to kindly take the above information in your records.

Thanking You, For JHS Svendgaard Laboratories Limited

dy Company Secretar, Kirti Maheshwari Compliance OF

Company Secretary and Compliance Officer

Encl: A/a

q| | | 4 nf 1 | Registered Office : Trilokpur Road, Kheri (Kala-Amb), Tehsil-Nahan, Distt. Sirmour, Himachal Pradesh - 173030, INDIA |7 Tel. : +91-1702-302119/121/102 - Fax ; +91-1702-302125 L

S.N. Dhawan & CO LLP Gurugram, Haryana 122016, India

421, Il Floor, Udyog Vihar Phase IV,

Chartered Accountants Tel: +91 124 481 4444ANNEXURE "A ANMESONS

Independent Auditor's Report

To the Board of Directors of JHS Svendgaard Laboratories Limited

Report on the Audit of Standalone Financial Results

Opinion

We have audited the Standalone Financial Results of JHS Svendgaard Laboratories Limited ('the Company") for the year ended 31 March 2021 included in the accompanying Statement of 'Standalone Financial Results for the quarter and year ended 31 March 2021 ("the Statement"), being submitted by the Company pursuant to the requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended ("the Listing Regulations ").

In our opinion and to the best of our information and according to the explanations given to us, the Statement:

i. is presented in accordance with the requirements of Regulation 33 of the Listing Regulations in this regard; and
ii, gives a true and fait view in conformity with the applicable Indian Accounting Standards prescribed under Section 133 of the Companies Act 2013 ("the Act") read with relevant rules issued thereunder and other accounting principles generally accepted in India, of the net profit and total comprehensive income and other financial information of the Company for the year ended 31 March 2021.

Basis for Opinion

We conducted our audit in accordance with the Standards on Auditing (SAs) specified under Section 143(10) of the Act. Our responsibilities under those Standards are further described in the Auditor's Responsibilities for the Audit of the Statement section of our report. We are independent of the Company in accordance with the Code of Ethics issued by the Institute of Chartered Accountants of India ("the ICAL") together with the ethical requirements that are relevant to our audit of the standalone financial statements under the provisions of the Act and the Rules thereunder, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the ICAI's Code of Ethics. We believe that the audit evidence obtained by us is sufficient and appropriate to provide a basis for our opinion.

Management's Responsibilities for the Statement

"This Statement has been prepared on the basis of the standalone annual financial statements. 'The Company's Board of Directors are responsible for the preparation and presentation of these Standalone Financial Results that give a true and fait view of the net profit and total comprehensive income and other financial information of the Company in accordance with the Indian Accounting Standards prescribed under Section 133 of the Act read with relevant rules issued thereunder and other accounting principles generally accepted in India and in compliance with Regulation 33 of the Listing Regulations. 'This responsibility also includes maintenance of adequate accounting records in accotdance with the provisions of the Act for safeguarding of the assets of the Company and for

S.N. Dhawan & CO LLP is registered with limited liability with identification number AAH-1125 and its registered office is 408, Mercantile House, 15, Kasturba Gandhi Marg, New Delhi 110001, India

preventing and detecting frauds and other irregularities; selection and application of appropriate accounting policies; making judgments and estimates that are reasonable and prudent; and the design, implementation and maintenance of adequate internal financial controls, that were operating effectively for ensuring accuracy and completeness of the accounting records, relevant to the preparation and presentation of the Standalone Financial Results that give a true and fair view and are free from material misstatement, whether due to fraud or error.

In preparing the Standalone Financial Results, the Board of Directors are responsible for assessing, the Company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the Board of Directors either intends to liquidate the Company or to cease operations, or has no realistic alternative but to do so.

The Board of Directors are also responsible for overseeing the financial reporting process of the Company.

Auditor's Responsibilities for the Audit of the Statement

Our objectives ate to obtain reasonable assurance about whether the Standalone Financial Results as awhole, are free from material misstatement, whether due to fraud or error, and to issue an auditot's report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with SAs will always detect a material misstatement when it exists, Misstatements can arise from fraud or error and are considered material if, individually ot in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these Standalone Financial Results.

As part of an audit in accordance with SAs, we exercise professional judgment and maintain professional skepticism throughout the audit. We also:

e Identify and assess the risks of material misstatement of the Standalone Financial Results, whether due to fraud or error, design and perform audit procedures responsive to those tisks, and obtain audit evidence that is sufficient and appropriate to provide a basis for out opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.
¢ Obtain an understanding of internal controls relevant to the audit in order to design audit procedures that are appropriate in the circumstances. Under Section 143(3) (i) of the Act, we are also responsible for expressing our opinion on whether the Company has adequate internal financial controls with reference to standalone financial statements in place and the operating effectiveness of such controls.
e Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by the Board of Directors.
eConclude on the appropriateness of the Board of Directors use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the ability of the Company to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in out auditor's report to the related disclosures in the Statement or, if such disclosures ate inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained

up to the date of our auditor's report. However, future events or conditions may cause the Company to cease to continue as a going concern.

eEvaluate the overall presentation, structure and content of the Standalone Financial Results, including the disclosures, and whether the Standalone Financial Results represent the underlying transactions and events in a manner that achieves fair presentation.

We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.

We also provide those charged with governance with a statement that we have complied with relevant ethical requirements regarding independence, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and where applicable, related safeguards.

Other Matters

'The Standalone Financial Results include the results for the quarter ended 31 March 2021 being the balancing figure between the audited figures in respect of the full financial year and the published unaudited year to date figures up to the third quarter of the current financial yeat which were subject to limited review by us.

For S.N. Dhawan & Co LLP Chartered Accountants Firm ei /N500045

(Surinder Kr. Khattar) Partner Membership No.: 084993

Place: New Delhi Date: 22 June 2021

JHS SVENDGAARD LABORATORIES LIMITED

Regd. Office: Trilokpur Road, Kheri (Kala-Amb), Tehsil Nahan, Distt. Sirmour, Himachal Pradesh - 173030, INDIA

CIN-124230HP2004PLC027558

STATEMENT OF AUDITED STANDALONE FINANCIAL RESULTS FOR THE QUARTER AND YEAR ENDED 31st MARCH, 2021

	31st March 2021Audited	31st Dec 2020Unaudited	31st March 2020Audited	31st March 2021Audited	31st March 2020Audited

	2,496.21	2.552.62	4,049.97	9,696.15	13,295.61
	324.15	38.38	702.62	554.78	1,175.32
	2,820.36	2,591.00	4,752.59	10,250.93	14,470.93

	1,436.72	1,707.39	2,820.02	6,402.24	9,496.24
		12.08	21.51	100.63	21.51
goods, work-in-progress and	79.77	(68.75)	74.27	179.83	190.13
	294.81	227.15	210.99	838.03	874.81
	12.57	9.76	3.37	45.25	136.11
	136.38	140.59	178.43	556.43	742.97
	624.24	463.03	575.64	1.808.81	1,766.38
	2,584.49	2,491.25	3,884.23	9,931.22	13,228.15
is and tax $(1-2)$	235.87	99.75	868.36	319.71	1,242.78
			(1,063,69)		(1.063.69)
	235.87	99.75	(195.33)	319.71	179.09
	28.12	24.45	100.85	52.57	180.87
	64.32	24.57	(185.47)	121.95	(152.38)
	(131.42)	$\mathbf r$	$\cdot$	(131.42)	(26.39)
	274.85	50.73	(110.71)	276.61	176.99

	8.13	(0.53)	(7.76)	6.53	(2.13)
-Income tax relating to items that will not be reclassified to profit or loss	(2.26)	0.15	2.16	(1.82)	0.60
	$\mathbf r$	¥	×	$,$	$\mathbf{I}$
profit or loss-Income tax relating to items that will be reclassified to	$\blacksquare$	$,$	ä	ú,
	280.72	50.35	(116.31)	281.32	175.46
value per share Rs. 10/-)	6.440.05	6,090.05	6,090.05	6,440.05	6,090.05
āper balance sheet				12,707.76	12.059.75

	0.44	0.08	(0.18)	0.45	0.29
	0.44	0.08	(0.18)	0.45	0.29

Standalone Statement of Assets and Liabilities

	Standalone Statement of Assets and LiabilitiesParticulars	As at 3st March	(% in lakhs)As at 31st March





















		2021Audited	2020Audited
A	ASSETS
	Non-eurrent assets
	(a) Property, plant and equipment	5,721.32	5,608.11
	(b) Capital work-in-progress	885.09	697.97
	(c) Right-of-use assets	146.98	174.41
	(d) Intangible assets	0.27	0.56
	(ce) Financial Assets
	(i) Investments(ii) Loans	1,421.00	1,421.00
	(iii) Others	12.6515.73.	11.0022.70
	(1) Deferred Tax Assets (net)	611.00	765.52
	(g) Non-current tax assets (net)	111.07	75.08
	(h) Other non-current assets	2,375.85	2,636.83
	Total non-current assets	11,300.96	11,413.18
	Current assets
	(a) Inventories	871.23	309.86
	(b) Financial Assets(i) Investments		230.66
	(ii) Trade receivables	-5,869.44	9,530.77
	(iii) Cash and cash equivalents	1,652.53	26.67
	(iv) Bank balances other than (iii) above	35,06	24.62
	(v) Loans	274.82	266.64
	(vi) Others	479,92	137.33
	(c) Other current assets	964.34	957.56
	(d) Assets classified as held for sale	-	11.42
	Total current assetsTotal assets	10,147.3421,448.30	11,495.5322,908.71
B	EQUITY AND LIABILITIES:
	Equity
	(a) Equity Share Capital	6,440.05	6,090.05
	(b) Other Equity	12,707.76	12,059.75
	Total equity	19,147.81	18,149.80
	LiabilitiesNon-current liabilities
	(a) Financial liabilities
	(i) Borrowings	33.29	35.57
	(ii) Lease liabilities	161.96	179.83
	(b) Provisions	128.85	110.33
	Total non-current liabilities	324.10	325.73
	Current liabilities
	(a) Financial liabilities(i) Borrowings
		-	-
		287,93	338.92
	(ii) Trade payables- total outstanding dues of micro and small enterprises
	- total outstanding dues of creditors other than micro and small	1.236.71	3.179.83
	enterprises
	(iii) Lease Liabilities	17.87	10.46
	(iii) Other financial liabilities	357.69	540.04
	(b) Other current liabilities	62.37	195.57
	(c) ProvisionsTotal current liabilities	13.821,976.39	168.364,433.18
	Total liabilities	2,300.49	4,758.91

JHS SVENDGAARD LABORATORIES LIMITED STANDALONE STATEMENT OF CASH FLOWS FOR THE YEAR ENDED 31 MARCH, 2021

	JHS SVENDGAARD LABORATORIES LIMITEDSTANDALONE STATEMENT OF CASH FLOWS FOR THE YEAR ENDED 31 MARCH, 2021
			(% in lakhs)
	Particulars	Year Ended31 March, 2021	Year Ended31 March, 2020
	Cash Flow from Operating ActivitiesProfit before exceptional items and tax	319.71	1,242.78
	Adjustments for:	(7.29)	(54.73)
	Provision for inventories written back (Net)Depreciation and AmortizationLoss on disposal of Property, Plant and Equipment (Net)	556.435,03	742.971.89
	Interest incomeGovernment grant amortization	(31,92)(3.00)	(43.24)(3.00)
	Provision no longer required written back	(353.02)328.67	(2.95)
	Balances and Advances written offintangible assets under development written off	(57.92)	(9.79)
	Balances and Advances written backInterest and financial chargesNet gain on financial asset mandatorily measured at PVTPI	45.25	-136.12(17.68)
	Exchange loss/(gain) (Net)	-61.66(15.83)	(615.96)(33.86)
	Fair value adjustmentsOperating profit before working capital changes	847.77	1,342.55
	Adjustinents for ;(Increase)/Decrease in inventories	(554.07)	458.50
	(Increase)/Decrease in trade receivables(Increase)/Decrease in Current Loans	3,598.134.50	(3,306.43)373.64
	(Increase)/Decrease in Other Current Assets(Increase)/Decrease in Asset Held for Sale	(6.78)5.42	756,97(7.03)
	(increase)/Decrease in Investment in bank deposits(ncrease)/Decrease in Other Current Financial assets	(10.44)(342.35)	1.29180.55
	(Increase)/Decrease in Non current Loans	(1.65)	=
	(Increase)/Decrease in Other non-current assetsIncrease/ (decrease) in Other Current Financial Liabilities	258.74(156.54)	1,291.86(120.17)
	increase/ (decrease) in Trade payablesIncrease/ (decrease) in Lease Liabilities	(1,941.30)7.42	1,265.1810.45
	Increase/ (decrease) in Short term provisionsIncrease/ (decrease) in Long term provisions	(0,39)18.52	1.6329.34
	increase/ (decrease) in Non Current finaneial liabilitiesincrease/ (decrease) in Other Current liabilities	17.88(125.09)	218.8363.57
	Cash (used) from operationsFaxes Paid	1,619.77(77.34)	2,560.7316.50
	Cash flow from exceptional itemsLoss on asset held for sale	-	(1,063.69)
	Net cash generated/(used) from operating activities	1,542.43	1,513.54
B.	Cash Flow from Investing ActivitiesPurchase of Property, Plant and Equipment	(832.10)	(833.82)
	Right-of-useProceeds from sale of Property, Plant and Equipment	2.831.20	174.412.83
	Purchase of Mutual Funds	(1,584.94)1,595.74	51.80
	Proceeds from sale of Mutual fundsProceeds from sale of debentures	234.96	;(150,00)
	Investments in subsidiary companiesInterest income received	-22.120.36	73.28
	Proceeds from repayment of loan to CorporatesLoan given to Shareholder	2	-4.63
	Change in Other bank balance and cash not available for immediate useNet Cash generated/(used) in investing activities	LSI(558.32)	0.75(676.12)
	Cash Flow from Financing Activities		(137.64)
	Proceeds from/ (repayment of) long term borrowingsProceeds from/ (repayment of) short term borrowings	(2.28)	(500.00)
	Repayment of lease liabilitiesProceed from share capital and securities premium	(35.75)700,00	(39.00)
	Proceed from of Share Warrant	25,00(45.22)
	Interest and financial charges.Net increase from financing activities	641.75

Net Inercase/(decrease) in cash and cash equivalents	1,625.86	(7.48)
Opening, balance of cash and cash equivalents	26.67	34,15
Closing balance of cash and cash equivalents	1,652.53	26.67
Components of cash and cash equivalents as at end of the year
Cash on hand	11.26	6.51
Balances with banks
- on current account	1,641.27	18.11
- in term deposits with original maturity of 3 months or less	-	2.05
Cash and bank balance	1,652.53	26.67

Notes:
The above audited standalone financial results have been reviewed by the Audit Committee and approved by the Board of Directors of the Company in theof thehave been audited by the Statutory Auditors of the Company as required under Regulation 33Securities and Exchange Board of India (Listing Obligations and Disclosure requirements) Regulation, 2015respective meetings held on 22nd June, 2021. The same
20 per warrant. Out of this, the Compnay has converted 35,00,000 fully convertible share warrants in to equal number of fully paid equity shares after receivingfull issue price of Rs. 20 per warrant from the respective allottees. The said equity shares were listed with stock exchange in March 2021. Balance 5,00,000 fullyPursuant to approval of shareholders by way of special resolution in accordance with section 42 & 62 of the Companies Act, 2013 and Rules made thereunder andas per SEBI (ICDR) Regulations, 2018 the Company approved preferential allotment of 40,00,000 fully convertible warrants of Rs. 10 each at an issue price of Rs.covertible warrants pending for conversion as on 31st March, 2021 against which the Compnay has received Rs. 25 Lakhs being 25% upfront money
to adjust the outstanding export dues against the goods received. Accordingly, the net consideration ofThe Company has entered into tripartite agreement to settle its export outstanding dues with one of its customer. Simultaneously, during the year Company hasreceived the goods amounting to Rs 1,917.15 Lakhs and given to the third party as per tripartite agreement at a consideration of Rs 1,955.49 Lakhs. The Companythis transaction amounting to Rs. 38.34 Lakhs has been shown in other income.has taken necessary permission from the concerned bank
In line with the provisions of Ind AS 108 - Operating Segments and on the basis the review of operations being done by the Management, the operations of thewhich is considered to be the only reportable segment by the management.Company fall under Manufacturing of Oral Care products,
draft Composite Scheme to the Securities and Exchange Board of India for its comments. After approval of Scheme from Stock Exchanges, the Composite Schemeand JHS Svendgaard Brands Limited (Transferor Company) ('Composite Scheme') under Section 230-232 of the Companies Act, 2013. Thereafter, the companyhas filed application with BSE Limited and National Stock Exchange of India Limited for seeking no objection. At present the stock exchanges have forwarded theamong JHS Svendgaard Laboratories Limited (Demerged Company/ Transferee Company), JHS Svendgaard Retail Ventures Private Limited (Resulting Company)2020 has approved the Composite Scheme of Arrangement for Amalgamation and Demerger betweenis subject to the approval of creditors and shareholders of the Company and the sanction by the NCLT and other statutory authorities.The Company in its board meeting held on 09th October,
current estimates expects that the carrying amount of these assets will be recovered. Further, the Company has considered internal and external information uptoThe Company has considered the possible effects that may result from the pandemic on the carrying amounts of its property, plant and equipment, investments,inventories, receivables and other current assets and liabilities. The Company has also evaluated its liquidity position, recoverability of its assets and based onBased on the above, there has been no material impact on the operations or profitability of the Companythe date of approval of these standalone financial results.due to this pandemic.
Lakhs for the current quarter and year ended 31st March, 2021.Deferred tax includes MAT credit entitlement of Rs. 52.57
The standalone financial results include the results for the quarter ended 31st March, 2021 and 31st March, 2020 being the balancing figure between the auditedfigures in respect of the full financial year and the published unaudited year to date figures up to the third quarter of the respective financial years.
For and on behalf of Board of Directorsd and reclassified to conform with current quarter/year presentation, where ever applicableFigures for the previous quarters/years have been regroupe
toriesManaging Director $\frac{3}{4}$ poxNew DelhiNikhil NandaPlace: New Delhi
DIN: 00051501Date: 22nd June, 2021

$\mathcal{L}$

$\overline{4}$

$\circ$

$\overline{c}$

$\overline{\phantom{0}}$

$\overline{\mathcal{C}}$

$\sigma$

$\infty$

S.N. Dhawan & co LLP Gurugram, Haryana 122016, India

Chartered Accountants Tel: +91 124 481 4444

421, ll Floor, Udyog Vihar Phase IV,

Independent Auditor's Report

To the Board of Directors of JHS Svendgaard Laboratories Limited